HonorStocks Biotech Gold Oil Mining China Asian MENU
Biotech Gold Oil Mining China Asian
Find Tomorrow's Winners Today

Stock technical analysis
Rating Flag Rating Flag Rating Flag Rating Flag Rating Flag
sell neutral buy
Aytu BioScience, Inc. (AYTU)
1.33  0.01  (0.76%) 07-09 15:59
Open: 1.32 High: 1.35
Pre.close: 1.32 Low: 1.28
Volume: 4,561,206 Ave vol: 13,817,037
52w High: 2.99 52w Low: 0.34
MA(50): 1.47 MA(200): 1.235
EPS: -0.249 P/E Ratio: 0
Company profile
Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Website: http://aytubio.com
Market Cap (M): 160
Shares Out (M): 121
Aytu BioScience, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel products in the field of hypogonadism (low testosterone), cough and upper respiratory symptoms, insomnia, and male infertility in the United States and internationally. The company markets Natesto, a nasal gel for the treatment of hypogonadism (low testosterone) in men; and Tuzistra XR, a prescription antitussive consisting of codeine polistirex and chlorpheniramine polistirex in an oral suspension. It also offers ZolpiMist, an oral spray for the treatment of insomnia; and MiOXSYS, an in vitro diagnostic semen analysis test that is used in the measurement of static oxidation reduction potential in human semen. Aytu BioScience, Inc. is based in Englewood, Colorado.
Technical analysis
Overall: Underperform
MA: Bearish MACD: Bearish
KDJ: Bearish RSI: Bearish
Target 1: 1.80 Target 2: 1.99
Resist 1: 1.54 Resist 2: 1.70
Support 1: 1.28 Support 2: 1.06
Company key metrics
Revenue per Share: 0.9392
Net Income per Share: -3.4809
Cash per Share: 1.4169
Book Value per Share: 0.9093
Price to Sales: 1.7036
Price to Book Value: 1.7595
Earnings Yield: -2.1756
Dividend Yield: 0
Debt to Equity: 3.8987
Debt to Assets: 0.7959
Financial analysis
Price to Book Value: Neutral
Return on Assets: Neutral
Return on Equity: Neutral
Discounted cash flow: Outperform
Price to Earnings: Underperform
Debt to Equity: Outperform
Stock Charts
Headline news
Tue, 07 Jul 2020
Is Aytu Bioscience (AYTU) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance

Wed, 08 Jul 2020
Gear up for the change! Aytu BioScience Inc. (AYTU) has hit the volume of 3273683 - The InvestChronicle

Thu, 25 Jun 2020
All You Need to Know About Aytu Bioscience, Inc. (AYTU) Rating Upgrade to Strong Buy - Yahoo Finance

Mon, 06 Jul 2020
Aytu BioScience, Inc. (AYTU) - good time to look at fundamentals - The News Heater

Fri, 12 Jun 2020
Why Aytu BioScience (AYTU) Stock Might be a Great Pick - Yahoo Finance

Thu, 02 Jul 2020
Surging COVID-19 Cases Could Alter Aytu BioScienceā€™s Path to Profitability - 24/7 Wall St.

HonorStocks, Find Tomorrow's Winners Today

Ā©HonorStocks.com | U.S. stock markets, stock quotes and stock analysis. Data and information is provided for informational purposes only, is not intended for trading purposes and is not investment advice. Neither HonorStocks.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Market data provided by: IEX and Financial Modeling Prep

Privacy Policy: Third parties, including Google, may be placing and reading cookies on your browsers, or other methods to collect information as a result of ad serving on this website. Google's use of advertising cookies enables it and its partners to serve ads to you based on your visit to this site and/or other sites on the Internet. You may opt out of personalized advertising by visiting Ads Settings. If you choose to use this website, you agree to the collection and use of information in relation to this policy. The information collected is used for providing and improving the ads Service. We will not use or share information with anyone, and we do not store any data from users.